Interactions between tau and α-synuclein augment neurotoxicity in a Drosophila model of parkinson's disease

Human Molecular Genetics

Volumn 23, Issue 11, 2014, Pages 3008-3023

  Roy, Bidisha ^a   Jackson, George R ^a,b,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN; PROTEIN BINDING;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FRUIT FLY MODEL; GENETIC ASSOCIATION; IMAGINAL DISC; NERVE FIBER TRANSPORT; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; TAUOPATHY; ANIMAL; APOPTOSIS; CYTOLOGY; CYTOSKELETON; DISEASE MODEL; DROSOPHILA; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; TOXICITY; TRANSGENIC ANIMAL;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; CYTOSKELETON; DISEASE MODELS, ANIMAL; DROSOPHILA; HUMANS; NEURONS; PARKINSON DISEASE; PROTEIN BINDING; TAU PROTEINS;

EID: 84899984461     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu011     Document Type: Article

References (123)

1. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Watanabe, A., Titani, K. and Ihara, Y. (1995) Hyperphosphorylation of tau in PHF. Neurobiol. Aging, 16, 365-371.
2. Johnson, G.V. and Bailey, C.D. (2002) Tau, where are we now? J. Alz. Dis., 4, 375-398.
3. Cookson,M.R.(2005)The biochemistry of Parkinson's disease. Annu. Rev. Biochem., 74, 29-52.
4. Wersinger, C. and Sidhu, A. (2005) Disruption of the interaction of αsynuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry, 44, 13612-13624.
5. Hamilton, R.L. (2000) Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol., 10, 378-384.
6. Kotzbauer, P.T., Trojanowski, J.Q. and Lee, V.M. (2001) Lewy body pathology in Alzheimer's disease. J. Mol. Neurosci., 17, 225-232.
7. Arai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G. and Katayama, Y. (2001)α-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. Brain Res., 888, 287-296.
8. Hishikawa, N., Hashizume, Y., Ujihira, N., Okada, Y., Yoshida, M. and Sobue, G. (2003) α-Synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification. Neuropath. Appl. Neurobiol., 29, 280-287.
9. Popescu, A., Lippa, C.F., Lee, V.M. and Trojanowski, J.Q. (2004) Lewy bodies in the amygdala: increase of α-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch. Neurol., 61, 1915-1919.
10. Trembath, Y., Rosenberg, C., Ervin, J.F., Schmechel, D.E., Gaskell, P., Pericak-Vance, M., Vance, J. and Hulette, C.M. (2003) Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease. Acta Neuropathol., 105, 484-488.
11. Lippa, S.M., Lippa, C.F. and Mori, H. (2005) α-synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. Am. J. Alz. Dem., 20, 315-318.
12. Lippa, C.F., Schmidt, M.L., Lee, V.M. and Trojanowski, J.Q. (1999) Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann. Neurol., 45, 353-357.
13. Arima, K., Hirai, S., Sunohara, N., Aoto, K., Izumiyama, Y., Ueda, K., Ikeda, K. and Kawai, M. (1999) Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Brain Res., 843, 53-61.
14. Ishizawa, T., Mattila, P., Davies, P., Wang, D. and Dickson, D.W. (2003) Colocalization of tau and α-synuclein epitopes in Lewy bodies. J. Neuropathol. Exp. Neurol., 62, 389-397.
15. Edwards, T.L., Scott, W.K., Almonte, C., Burt, A., Powell, E.H., Beecham, G.W., Wang, L., Zuchner, S., Konidari, I., Wang, G. et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet., 74, 97-109.
16. Simon-Sanchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S.W., Hernandez, D.G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet., 41, 1308-1312.
17. Devine, M.J. and Lewis, P.A. (2008) Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2. FEBS J., 275, 5748-5757.
18. +, induces hyperphosphorylation of Tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells. Neurotox. Res., 10, 1-10.
19. Duka, T., Rusnak, M., Drolet, R.E., Duka, V., Wersinger, C., Goudreau, J.L. and Sidhu, A. (2006) α-synuclein induces hyperphosphorylation of tau in the MPTP model of parkinsonism. FASEB J., 20, 2302-2312.
20. Duka, T., Duka, V., Joyce, J.N. and Sidhu, A. (2009) α-Synuclein contributes to GSK-3β-catalyzed tau phosphorylation in Parkinson's disease models. FASEB J., 23, 2820-2830.
21. Haggerty, T., Credle, J., Rodriguez, O., Wills, J., Oaks, A.W., Masliah, E. and Sidhu, A. (2011) Hyperphosphorylated tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease. Eur. J. Neurosci., 33, 1598-1610.
22. Giasson, B.I., Forman, M.S., Higuchi, M., Golbe, L.I., Graves, C.L., Kotzbauer, P.T., Trojanowski, J.Q. and Lee, V.M. (2003) Initiation and synergistic fibrillization of tau and α-synuclein. Science, 300, 636-640.
23. Kotzbauer, P.T., Giasson, B.I., Kravitz, A.V., Golbe, L.I., Mark, M.H., Trojanowski, J.Q. and Lee, V.M. (2004) Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation. Exp. Neurol., 187, 279-288.
24. Trinh, K., Moore, K., Wes, P.D., Muchowski, P.J., Dey, J., Andrews, L. and Pallanck, L.J. (2008) Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease. J. Neurosci., 28, 465-472.
25. Ambegaokar, S.S. and Jackson, G.R. (2011) Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum. Mol. Genet., 20, 4947-4977.
26. Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron, 34, 509-519.
27. Ambegaokar, S.S. and Jackson, G.R. (2010) Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster. Genetics, 186, 435-442.
28. Fan, Y., Lee, T.V., Xu, D., Chen, Z., Lamblin, A.F., Steller, H. and Bergmann, A. (2010) Dual roles of Drosophila p53 in cell death and cell differentiation. Cell Death Diff., 17, 912-921.
29. Kato, K., Awasaki, T. and Ito, K. (2009) Neuronal programmed cell death induces glial cell division in the adult Drosophila brain. Development, 136, 51-59.
30. Betz, A., Ryoo, H.D., Steller, H. and Darnell, J.E. Jr. (2008) STAT92E is a positive regulator of Drosophila inhibitor of apoptosis 1 (DIAP/1) and protects against radiation-induced apoptosis. Proc. Natl. Acad. Sci. USA, 105, 13805-13810.
31. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A.,Drummond, J.A., Berg, S.,MacKay, D. et al. (2004)GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psych., 9, 522-530.
32. Alonso, A.D., Zaidi, T., Novak, M., Barra, H.S., Grundke-Iqbal, I. and Iqbal, K. (2001) Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J. Biol. Chem., 276, 37967-37973.
33. Abraha, A., Ghoshal, N., Gamblin, T.C., Cryns, V., Berry, R.W., Kuret, J. and Binder, L.I. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci., 113, 3737-3745.
34. Jeannotte, A.M. and Sidhu, A. (2008) Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons. J. Neurochem., 105, 1668-1682.
35. Kotani, S., Nishida, E., Kumagai, H. and Sakai, H. (1985) Calmodulin inhibits interaction of actin with MAP2 and Tau, two major microtubule-associated proteins. J. Biol. Chem., 260, 10779-10783.
36. Correas, I., Padilla, R. and Avila, J. (1990) The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding. Biochem. J., 269, 61-64.
37. Moraga, D.M., Nunez, P., Garrido, J. and Maccioni, R.B. (1993) A tau fragment containing a repetitive sequence induces bundling of actin filaments. J. Neurochem., 61, 979-986.
38. Henriquez, J.P., Cross, D., Vial, C. and Maccioni, R.B. (1995) Subpopulations of tau interact with microtubules and actin filaments in various cell types. Cell Biochem. Funct., 13, 239-250.
39. He, H.J., Wang, X.S., Pan, R., Wang, D.L., Liu, M.N. and He, R.Q. (2009) The proline-rich domain of tau plays a role in interactions with actin. BMC Cell Biol., 10, 81.
40. Hummel, T., Krukkert, K., Roos, J., Davis, G. and Klambt, C. (2000) Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development. Neuron, 26, 357-370.
41. Ratnaparkhi, A., Lawless, G.M., Schweizer, F.E., Golshani, P. and Jackson, G.R. (2008)ADrosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE, 3, e2334.
42. Viquez, N.M., Li, C.R., Wairkar, Y.P. and DiAntonio, A. (2006) The B' protein phosphatase2Aregulatory subunit well-rounded regulates synaptic growth and cytoskeletal stability at the Drosophila neuromuscular junction. J. Neurosci., 26, 9293-9303.
43. Pennetta, G., Hiesinger, P.R., Fabian-Fine, R., Meinertzhagen, I.A. and Bellen, H.J. (2002) Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron, 35, 291-306.
44. Packard, M., Koo, E.S., Gorczyca, M., Sharpe, J., Cumberledge, S. and Budnik, V. (2002) The Drosophila Wnt, wingless, provides an essential signal for pre- and postsynaptic differentiation. Cell, 111, 319-330.
45. Coleman, M. (2005) Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci., 6, 889-898.
46. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B. and Mandelkow, E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol., 143, 777-794.
47. Nuydens, R., Van Den Kieboom, G., Nolten, C., Verhulst, C., Van Osta, P., Spittaels, K., Van den Haute, C., De Feyter, E., Geerts, H. and Van Leuven, F. (2002) Coexpression of GSK-3b corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau. Neurobiol. Dis., 9, 38-48.
48. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.M. (2002) Tau blocks traffic of organelles, neurofilaments, and APPvesicles in neurons and enhances oxidative stress. J. Cell Biol., 156, 1051-1063.
49. Talmat-Amar, Y., Arribat, Y., Redt-Clouet, C., Feuillette, S., Bouge, A.L., Lecourtois, M. and Parmentier, M.L. (2011) Important neuronal toxicity of microtubule-bound tau in vivo in Drosophila. Hum. Mol. Genet., 20, 3738-3745.
50. Hurd, D.D. and Saxton, W.M. (1996) Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics, 144, 1075-1085.
51. Liu, Z., Huang, Y., Zhang, Y., Chen, D. and Zhang, Y.Q. (2011) Drosophila Acyl-CoA synthetase long-chain family member 4 regulates axonal transport of synaptic vesicles and is required for synaptic development and transmission. J. Neurosci., 31, 2052-2063.
52. Wagh, D.A., Rasse, T.M., Asan, E., Hofbauer, A., Schwenkert, I., Durrbeck, H., Buchner, S., Dabauvalle, M.C., Schmidt, M., Qin, G. et al. (2006) Bruchpilot, a protein with homology to ELKS/CAST,is required for structural integrity and function of synaptic active zones in Drosophila. Neuron, 49, 833-844.
53. Horiuchi, D., Collins, C.A., Bhat, P., Barkus, R.V., Diantonio, A. and Saxton, W.M. (2007) Control of a kinesin-cargo linkage mechanism by JNK pathway kinases. Curr. Biol., 17, 1313-1317.
54. Schulz-Schaeffer, W.J. (2010) The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol., 120, 131-143.
55. Kramer, M.L., Behrens, C. and Schulz-Schaeffer, W.J. (2008) Selective detection, quantification, and subcellular location of α-synuclein aggregates with a protein aggregate filtration assay. BioTechniques, 44, 403-411.
56. Davidson, W.S., Jonas, A., Clayton, D.F. and George, J.M. (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem., 273, 9443-9449.
57. Jenco, J.M., Rawlingson, A., Daniels, B. and Morris, A.J. (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins. Biochemistry, 37, 4901-4909.
58. Bonini, N.M. and Giasson, B.I. (2005) Snaring the function of α-synuclein. Cell, 123, 359-361.
59. Burre, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M.R. and Sudhof, T.C. (2010) α-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science, 329, 1663-1667.
60. Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O.M. and Sudhof, T.C. (2005) α-synuclein cooperates with CSPα in preventing neurodegeneration. Cell, 123, 383-396.
61. Darios, F., Ruiperez, V., Lopez, I., Villanueva, J., Gutierrez, L.M. and Davletov, B. (2010) α-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep., 11, 528-533.
62. Engelender, S., Kaminsky, Z., Guo, X., Sharp, A.H., Amaravi, R.K., Kleiderlein, J.J., Margolis, R.L., Troncoso, J.C., Lanahan, A.A., Worley, P.F. et al. (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet., 22, 110-114.
63. Garcia-Reitbock, P., Anichtchik, O., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B., Della Corte, L., Spano, P., Tofaris, G.K. et al. (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain, 133, 2032-2044.
64. Scott, D.A., Tabarean, I., Tang, Y., Cartier, A., Masliah, E. and Roy, S. (2010) A pathologic cascade leading to synaptic dysfunction in α-synuclein-induced neurodegeneration. J. Neurosci., 30, 8083-8095.
65. Sousa, V.L., Bellani, S., Giannandrea, M., Yousuf, M., Valtorta, F., Meldolesi, J. and Chieregatti, E. (2009) α-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. Mol. Biol. Cell, 20, 3725-3739.
66. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A. et al. (2000) Mice lacking a display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239-252.
67. Gureviciene, I., Gurevicius, K. and Tanila, H. (2007) Role of alpha-synuclein in synaptic glutamate release. Neurobiol. Dis., 28, 83-89.
68. Nemani, V.M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M.K., Chaudhry, F.A., Nicoll, R.A. and Edwards, R.H. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron, 65, 66-79.
69. Binder, L.I., Frankfurter, A. and Rebhun, L.I. (1985) The distribution of tau in the mammalian central nervous system. J. Cell Biol., 101, 1371-1378.
70. Thies, E. and Mandelkow, E.M. (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci., 27, 2896-2907.
71. Lasagna-Reeves, C.A., Castillo-Carranza, D.L., Sengupta, U., Clos, A.L., Jackson, G.R. and Kayed, R. (2011) Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol. Neurodegener., 6, 39.
72. Chee, F.C., Mudher, A., Cuttle, M.F., Newman, T.A., MacKay, D., Lovestone, S. and Shepherd, D. (2005) Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol. Dis., 20, 918-928.
73. Akbergenova, Y. and Bykhovskaia, M. (2010) Synapsin regulates vesicle organization and activity-dependent recycling at Drosophila motor boutons. Neuroscience, 170, 441-452.
74. Wang, P., Yang, G., Mosier, D.R., Chang, P., Zaidi, T., Gong, Y.D., Zhao, N.M., Dominguez, B., Lee, K.F., Gan, W.B. et al. (2005) Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2. J. Neurosci., 25, 1219-1225.
75. Iseki, E., Marui, W., Kosaka, K. and Ueda, K. (1999) Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci. Lett., 265, 9-12.
76. Yogev, S., Schejter, E.D. and Shilo, B.Z. (2008) Drosophila EGFR signalling is modulated by differential compartmentalization of Rhomboid intramembrane proteases. EMBO J., 27, 1219-1230.
77. Haass, C. and Selkoe, D.J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol., 8, 101-112.
78. Bruijn, L.I., Houseweart, M.K., Kato, S., Anderson, K.L., Anderson, S.D., Ohama, E., Reaume, A.G., Scott, R.W. and Cleveland, D.W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science, 281, 1851-1854.
79. Forman, M.S., Trojanowski, J.Q. and Lee, V.M. (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med., 10, 1055-1063.
80. Soto, C., Estrada, L. and Castilla, J. (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci., 31, 150-155.
81. Orr, H.T. and Zoghbi, H.Y. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci., 30, 575-621.
82. Wills, J., Credle, J., Haggerty, T., Lee, J.H., Oaks, A.W. and Sidhu, A. (2011) Tauopathic changes in the striatum of A53T alpha-synuclein mutant mouse model of Parkinson's disease. PLoS ONE, 6, e17953.
83. Bowie, J.U. (2004)Membraneproteins: a new method enters the fold. Proc. Natl. Acad. Sci. USA, 101, 3995-3996.
84. Molloy, M.P., Herbert, B.R., Walsh, B.J., Tyler, M.I., Traini, M., Sanchez, J.C., Hochstrasser, D.F., Williams, K.L. and Gooley, A.A. (1998) Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis, 19, 837-844.
85. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
86. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 18, 106-108.
87. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 55, 164-173.
88. Ibanez, P., Bonnet, A.M., Debarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Durr, A. and Brice, A. (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet, 364, 1169-1171.
89. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
90. Ingram, E.M. and Spillantini, M.G. (2002) Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med., 8, 555-562.
91. Chatterjee, S., Sang, T.K., Lawless, G.M. and Jackson, G.R. (2009) Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet., 18, 164-177.
92. Wills, J., Credle, J., Oaks, A.W., Duka, V., Lee, J.H., Jones, J. and Sidhu, A. (2012) Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways. PLoS ONE, 7, e30745.
93. Jensen, P.H., Hager, H., Nielsen, M.S., Hojrup, P., Gliemann, J. and Jakes, R. (1999) α-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem., 274, 25481-25489.
94. Benussi, L., Ghidoni, R., Paterlini, A., Nicosia, F., Alberici, A.C., Signorini, S., Barbiero, L. and Binetti, G. (2005) Interaction between tau and α-synuclein proteins is impaired in the presence of P301Ltau mutation. Exp. Cell Res., 308, 78-84.
95. Ubhi, K.K., Shaibah, H., Newman, T.A., Shepherd, D. and Mudher, A. (2007)Acomparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Invert. Neurosci., 7, 165-171.
96. Chau, M.F., Radeke, M.J., de Ines, C., Barasoain, I., Kohlstaedt, L.A. and Feinstein, S.C. (1998) The microtubule-associated protein tau cross-links to two distinct sites on eachaandbtubulinmonomer via separate domains. Biochem., 37, 17692-17703.
97. Zhou, R.M., Huang, Y.X., Li, X.L., Chen, C., Shi, Q., Wang, G.R., Tian, C., Wang, Z.Y., Jing, Y.Y., Gao, C. et al. (2010) Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells. Mol. Biol. Rep., 37, 3183- 3192.
98. Alim, M.A., Ma, Q.L., Takeda, K., Aizawa, T., Matsubara, M., Nakamura, M., Asada, A., Saito, T., Kaji, H., Yoshii, M. et al. (2004) Demonstration of a role for α-synuclein as a functional microtubule-associated protein. J. Alz. Dis., 6, 435-442.
99. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science, 298, 789-791.
100. Calabresi, P., Galletti, F., Saggese, E., Ghiglieri, V. and Picconi, B. (2007) Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. Parkins. Rel. Dis., 13, S259-S262.
101. Lee, S., Liu, H.P., Lin, W.Y., Guo, H. and Lu, B. (2010) LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction. J. Neurosci., 30, 16959-16969.
102. Godena, V.K., Romano, G., Romano, M., Appocher, C., Klima, R., Buratti, E., Baralle, F.E. and Feiguin, F. (2011) TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization. PLoS ONE, 6, e17808.
103. Fortin, D.L., Troyer, M.D., Nakamura, K., Kubo, S., Anthony, M.D. and Edwards, R.H. (2004) Lipid rafts mediate the synaptic localization of α-synuclein. J. Neurosci., 24, 6715-6723.
104. Perlmutter, J.D., Braun, A.R. and Sachs, J.N. (2009) Curvature dynamics of α-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms. J. Biol. Chem., 284, 7177-7189.
105. van Rooijen, B.D., Claessens, M.M. and Subramaniam, V. (2010) Membrane interactions of oligomeric α-synuclein: potential role in Parkinson's disease. Curr. Prot. Pept. Sci., 11, 334-342.
106. van Rooijen, B.D., Claessens, M.M. and Subramaniam, V. (2010) Membrane permeabilization by oligomeric α-synuclein: in search of the mechanism. PLoS ONE, 5, e14292.
107. Zhu, M., Li, J. and Fink, A.L. (2003) The association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation. J. Biol. Chem., 278, 40186-40197.
108. Alim, M.A., Hossain, M.S., Arima, K., Takeda, K., Izumiyama, Y., Nakamura, M., Kaji, H., Shinoda, T., Hisanaga, S. and Ueda, K. (2002) Tubulin seeds α-synuclein fibril formation. J. Biol. Chem., 277, 2112-2117.
109. Kim, M., Jung, W., Lee, I.H., Bhak, G., Paik, S.R. and Hahn, J.S. (2008) Impairment of microtubule system increases α-synuclein aggregation and toxicity. Biochem. Biophys. Res. Commun., 365, 628-635.
110. Takahashi, Y., Hirose, F., Matsukage, A. and Yamaguchi, M. (1999) Identification of three conserved regions in the DREF transcription factors from Drosophila melanogaster and Drosophila virilis. Nucleic Acids Res., 27, 510-516.
111. Friggi-Grelin, F., Coulom, H., Meller, M., Gomez, D., Hirsh, J. and Birman, S. (2003) Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. J. Neurobiol., 54, 618-627.
112. Lin, D.M. and Goodman, C.S. (1994) Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron, 13, 507-523.
113. Aberle, H., Haghighi, A.P., Fetter, R.D., McCabe, B.D., Magalhaes, T.R. and Goodman, C.S. (2002) wishful thinking encodes aBMPtype II receptor that regulates synaptic growth in Drosophila. Neuron, 33, 545-558.
114. Keller, L.C., Cheng, L., Locke, C.J., Muller, M., Fetter, R.D. and Davis, G.W. (2011) Glial-derived prodegenerative signaling in the Drosophila neuromuscular system. Neuron, 72, 760-775.
115. Jhaveri, D., Sen, A. and Rodrigues, V. (2000) Mechanisms underlying olfactory neuronal connectivity in Drosophila: the atonal lineage organizes the periphery while sensory neurons and glia pattern the olfactory lobe. Dev. Biol., 226, 73-87.
116. Wu, J.S. and Luo, L. (2006) A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat. Prot., 1, 2110-2115.
117. Marrus, S.B., Portman, S.L., Allen, M.J., Moffat, K.G. and DiAntonio, A. (2004) Differential localization of glutamate receptor subunits at the Drosophila neuromuscular junction. J. Neurosci., 24, 1406-1415.
118. Wairkar, Y.P., Fradkin, L.G., Noordermeer, J.N. and DiAntonio,A. (2008) Synaptic defects in a Drosophila model of congenital muscular dystrophy. J. Neurosci., 28, 3781-3789.
119. Daniels, R.W., Collins, C.A., Gelfand, M.V., Dant, J., Brooks, E.S., Krantz, D.E. and DiAntonio, A. (2004) Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J. Neurosci., 24, 10466-10474.
120. Sang, T.K., Li, C., Liu, W., Rodriguez, A., Abrams, J.M., Zipursky, S.L. and Jackson, G.R. (2005) Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. Hum. Mol. Genet., 14, 357-372.
121. Sang, T.K., Chang, H.Y., Lawless, G.M., Ratnaparkhi, A., Mee, L., Ackerson, L.C., Maidment, N.T., Krantz, D.E. and Jackson, G.R. (2007) A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J. Neurosci., 27, 981-992.
122. Viquez, N.M., Fuger, P., Valakh, V., Daniels, R.W., Rasse, T.M. and DiAntonio, A. (2009)PP2Aand GSK-3beta act antagonistically to regulate active zone development. J. Neurosci., 29, 11484-11494.
123. Jan, L.Y. and Jan, Y.N. (1982) Antibodies to horseradish peroxidase as specific neuronal markers in Drosophila and in grasshopper embryos. Proc. Natl. Acad. Sci. USA, 79, 2700-2704.